Our representative clients lead the way in developing therapies, devices and services that challenge the traditional approach to healthcare.

Our core capabilities include strategic direction and tactical communications planning for:

Start-up ventures such as a biotech company co-formed out of a university lab.


Emerging growth companies such a medical device product seeking FDA approval.

Middle market companies such as a healthcare IT company with a ripe EBIDTA valuation, eager to merge/be acquired by a larger partner.

Private equity portfolio healthcare companies who seek to tell their story in order to attract suitors for an exit.

Venture capital portfolio companies such as a medical technology company with new management, ready to launch/expand into different markets.

We turn your IP, products and services into credible and accepted value propositions that your target audiences thoroughly understand. 

Have a question? Contact Us.

Name *